Results 181 to 190 of about 803,750 (296)
Adenosine receptors and acute kidney injury: perspectives for future therapy. [PDF]
Wissmann IB +3 more
europepmc +1 more source
Adenosine receptors differentially mediate enteric glial cell death induced by Clostridioides difficile Toxins A and B. [PDF]
Costa DVS +8 more
europepmc +1 more source
Cloperastine suppresses osteoclastogenesis by inhibiting PGC1β‐mediated oxidative phosphorylation. Its incorporation into a ROS‐responsive, Asp8‐modified nanoplatform enhances skeletal accumulation. The resulting Clo/Asp8‐PMK‐MCs combine cloperastine‐mediated antiresorptive activity with carrier‐mediated osteogenic activity to attenuate OVX‐induced ...
Haibo Liang +16 more
wiley +1 more source
Mitochondrial Localization and Function of Adenosine Receptors. [PDF]
Sánchez-Melgar A +6 more
europepmc +1 more source
Guanosine modulates K+ membrane currents in SH-SY5Y cells: involvement of adenosine receptors. [PDF]
Gambino G +12 more
europepmc +1 more source
A biomimetic platelet nanoplatform (OE‐ACAD11@R‐PLT) is developed for targeted hepatocellular carcinoma immunotherapy. By selectively delivering therapeutic plasmids, this system induces mitochondrial dysfunction and triggers robust NLRP3/Caspase‐1/GSDMD‐mediated pyroptosis in tumor cells.
Hongyi Bao +12 more
wiley +1 more source
Computational discovery of natural medicines targeting adenosine receptors for metabolic diseases. [PDF]
Wang P +7 more
europepmc +1 more source
Role of cardiac β1-adrenergic and A1-adenosine receptors in severe arrhythmias related to Parkinson's disease. [PDF]
Menezes-Rodrigues FS +9 more
europepmc +1 more source
We fabricated a thermoelectric nanomedicine to disrupt the ATP energy supply for the copper transporter ATP7B, thereby enhancing cuproptosis and achieving synergistic immunotherapy for anti‐tumor purposes. The fabricated TBCT NFs can efficiently disrupt the electron transport chain function via superoxide‐induced NADH oxidation, leading to ATP ...
Haoyang Du +13 more
wiley +1 more source

